Conclusion HSV-TK/GCV gene therapy system may provide a new therapeutic approach for treatment of osteosarcoma.
结论HSV-TK/GCV基因治疗系统可为骨肉瘤的治疗提供新途径。
The use of negative selection gene (HSV-tk) results in 7-fold increase at selection efficiency.
负向选择系统的应用使同源重组事件的富集效率提高了7倍。
The use of negative selection gene (HSV-tk) results in 7-fold increase at selection efficiency.
负向选择系统的应用使同源重组事件的富集效率提高了7倍。
应用推荐